Viewing Study NCT02032836



Ignite Creation Date: 2024-05-06 @ 2:25 AM
Last Modification Date: 2024-10-26 @ 11:17 AM
Study NCT ID: NCT02032836
Status: COMPLETED
Last Update Posted: 2018-09-26
First Post: 2014-01-09

Brief Title: Comparative PK PD Study in PAH Patients Fox vs I-Neb
Sponsor: Bayer
Organization: Bayer

Study Overview

Official Title: A Multi-center Open-label Randomized Cross-over Study to Compare the Acute Tolerability and Pharmacokinetics of BAYQ6256 Iloprost Ventavis Inhalation Using the I-Neb Nebulizer and the FOX Nebulizer in Patients With Pulmonary Arterial Hypertension
Status: COMPLETED
Status Verified Date: 2018-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Administration of iloprost aerosol comparing two nebulizers FOX and I-Neb
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
2013-002783-12 EUDRACT_NUMBER None None